Aperçu du marché et point de vue des analystes :
Les prévisions du marché des systèmes de protonthérapie peuvent aider les parties prenantes de ce marché à définir leurs stratégies de croissance.
Un système de protonthérapie est un dispositif médical avancé utilisé pour fournir un traitement par radiothérapie très précis pour les tumeurs. Ces systèmes sont de taille énorme et comprennent un accélérateur (cyclotron), un système de transport de faisceaux, un système de sélection d'énergie et un équipement d'irradiation à portique rotatif. En raison de son efficacité dans le traitement de certains types de cancer, la protonthérapie connaît une demande croissante dans le monde entier. Des facteurs tels que la demande croissante de traitements avancés avec l’incidence croissante du cancer et le soutien croissant du gouvernement aux centres de protonthérapie propulsent la croissance du marché des systèmes de protonthérapie. Cependant, le coût élevé et la vaste superficie des systèmes de protonthérapie entravent la croissance du marché. En outre, l'adoption croissante d'approches de traitement personnalisées accompagnées de progrès technologiques devrait entraîner de nouvelles tendances sur le marché des systèmes de protonthérapie dans les années à venir.
Moteurs de croissance :
Demande croissante de traitements avancés pour lutter contre la recrudescence du cancer. L'incidence stimule la croissance du marché
Selon le Centre international de recherche sur le cancer (CIRC), les types de cancer du poumon, du sein et de la prostate avaient le taux d'incidence le plus élevé en 2022. Ces maladies ont un taux standardisé selon l'âge de 23,6, 47,1 et 29,4 cas pour 100 000 habitants, respectivement. Selon les estimations du CIRC, le nombre total de cas de cancer devrait passer de 19,98 millions en 2022 à 23,71 millions en 2030 et à 30,97 millions en 2045. Diverses pathologies cancéreuses, telles que les cancers de la tête et du cou (du nez, de la bouche, des yeux, et du larynx) et les cancers du cerveau ont des exigences thérapeutiques précises, ce qui se traduit par une forte demande pour des approches thérapeutiques avancées telles que la protonthérapie à intensité modulée (IMPT). Dans les radiothérapies traditionnelles, telles que la radiothérapie aux rayons X, les tissus sains autour de la tumeur reçoivent également une dose de rayonnement, ce qui entraîne des effets secondaires et peut provoquer des cancers secondaires. Cependant, la protonthérapie contribue au traitement efficace des tumeurs compliquées du cerveau et de la région de la tête et du cou tout en minimisant les dommages collatéraux sur les tissus voisins. Ainsi, la forte prévalence du cancer et la demande de traitements avancés stimulent la demande de radiothérapie à base de protons, alimentant ainsi la croissance du marché des systèmes de protonthérapie.
Aperçus stratégiques
Retenue :
Coût élevé et vaste zone de systèmes de protonthérapie
Un système de protonthérapie est un dispositif médical avancé utilisé dans la radiothérapie de haute précision des tumeurs. Il s'agit d'un énorme dispositif médical composé d'un accélérateur (cyclotron), d'un système de transport de faisceaux, d'un système de sélection d'énergie et d'un équipement d'irradiation à portique rotatif, ce qui entraîne de grandes surfaces et un coût d'équipement élevé. Selon l'Université de Pennsylvanie (Oncolink), les cyclotrons des systèmes de protonthérapie pèsent jusqu'à 200 tonnes et ont un diamètre de 6 à 12 pieds. Le portique peut peser 100 tonnes et 40 pieds de diamètre. Selon une étude publiée (2021) dans IOPscience, même la conception compacte (installation dans une seule pièce) couvre une superficie de 100 m², tandis que les systèmes de protonthérapie multi-salles occupent 200 à 400 m². de superficie.
De plus, les systèmes de protonthérapie nécessitent une forte intensité de capital. Par exemple, un système pour une seule pièce peut coûter entre 30 et 50 millions de dollars. Le coût des systèmes à protons multi-portiques peut démarrer à partir de 300 millions de dollars américains et ils ne sont généralement installés que dans les grands hôpitaux et les systèmes universitaires. Par conséquent, les exigences élevées en matière d’investissement en capital et les grandes zones d’installation font partie des facteurs qui entravent la croissance du marché des systèmes de protonthérapie.
Segmentation et portée du rapport :
L’analyse du marché des systèmes de protonthérapie a été réalisée. en considérant les segments suivants : type d'installation et application.
Par type d'installation, le marché est divisé en pièce unique et multi-pièces. Le segment multi-salles détenait une part de marché plus importante des systèmes de protonthérapie en 2022. De plus, le segment des chambres simples devrait enregistrer un TCAC plus rapide au cours de la période de prévision.
Marché des systèmes de protonthérapie, par type d'installation - 2022 et 2030
Le marché, par application, est classé en cancer du cerveau et du système nerveux central, cancer de la tête et du cou, cancer de la prostate, cancer du sein, cancer du poumon, cancer gastro-intestinal et autres. Le segment du cancer du cerveau et du système nerveux central détenait la plus grande part de marché des systèmes de protonthérapie en 2022, et il devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.
Analyse régionale :
En termes En termes de géographie, la portée du rapport sur le marché des systèmes de protonthérapie comprend l’Amérique du Nord, l’Europe, l’Asie-Pacifique, l’Amérique du Sud et centrale, ainsi que le Moyen-Orient et l’Afrique. En 2022, l’Amérique du Nord représentait la plus grande part de marché. L’acceptation et l’adoption croissantes des derniers dispositifs médicaux, la forte prévalence du cancer et les innovations de produits par les principaux acteurs contribuent à l’expansion de la taille du marché des systèmes de protonthérapie en Amérique du Nord. Selon les estimations de l'American Cancer Society, les États-Unis ont enregistré environ 1,95 million de nouveaux cas de cancer et environ 0,61 million de décès liés à la maladie en 2023, ce qui représente une augmentation significative par rapport aux 1,60 million de cas de cancer et aux 0,60 million de décès signalés en 2020. Selon les estimations de l'American Cancer Society Therapy Co-Operative Group, à la fin de 2023, les États-Unis possédaient le plus grand nombre de systèmes de protonthérapie au monde, avec 46 installations de traitement par protonthérapie.
Développements de l'industrie et opportunités futures :
A Quelques développements stratégiques réalisés par les principaux acteurs opérant sur le marché des systèmes de protonthérapie, selon les communiqués de presse de la société, sont répertoriés ci-dessous :
•En janvier 2024, OncoRay a lancé le prototype d'un système guidé par IRM du corps entier. système de protonthérapie pour le suivi en temps réel des tumeurs en mouvement par imagerie par résonance magnétique (IRM) pendant la protonthérapie. L'IRM facilite la visualisation des tumeurs avec un contraste amélioré, ce qui constitue son avantage majeur par rapport aux modalités d'imagerie conventionnelles. Un meilleur contraste permet de mieux délimiter la tumeur des tissus sains environnants et de définir avec plus de précision le volume à irradier. En décembre 2023, HKSH Medical Group a ouvert un nouveau centre de protonthérapie au HKSH Eastern Medical Center en A. Kung Ngam, Shau Kei Wan, Hong Kong. Le nouveau centre dispose d'un système avancé de protonthérapie et de deux salles de traitement ultramodernes. Le système comprend deux portiques de protonthérapie semi-rotatifs, le dernier système de transport de faisceaux et un accélérateur basé sur un synchrotron. Paysage concurrentiel et entreprises clés :
Varian Medical Systems Inc, Sumitomo Heavy Industries Ltd, Hitachi Ltd, Ion Beam Applications SA, Mevion Medical Systems, Provision Healthcare LLC, ProTom International, Optivus Proton Therapy Inc, Advanced Oncotherapy plc et B dot Medical Inc font partie des principales sociétés présentées dans le rapport sur le marché des systèmes de protonthérapie. Ces entreprises se concentrent sur le développement de nouvelles technologies, la mise à niveau des produits existants et l'expansion de leur présence géographique pour répondre à la demande croissante des consommateurs du monde entier.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market, by application, is categorized into brain and central nervous system cancer, head and neck cancer, prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, and others. The brain and central nervous system cancer segment held the largest proton therapy systems market share in 2022, and it is anticipated to register the highest CAGR during the forecast period.
By setup type, the market is bifurcated into single room and multi room. The multi room segment held a larger proton therapy systems market share in 2022. Further, the single room segment is anticipated to register a faster CAGR during the forecast period.
The proton therapy systems market was valued at US$ 1,262.45 million in 2022.
The proton therapy systems market is expected to be valued at US$ 2,945.14 million in 2030.
The proton therapy systems market majorly consists of the players, including Varian Medical Systems Inc, Sumitomo Heavy Industries Ltd, Hitachi Ltd, Ion Beam Applications SA, Mevion Medical Systems, Provision Healthcare LLC, ProTom International, Optivus Proton Therapy Inc, Advanced Oncotherapy plc, and B dot Medical Inc
Factors such as rising demand for advanced treatments with the surging cancer incidence, and increasing government support for proton therapy centers propel the proton therapy systems market growth. However, the high cost and large area of proton therapy systems hamper the growth of the market.
A proton therapy system is an advanced medical device employed to provide a highly precise radiation treatment for tumors. These systems are huge in size, and they consist of an accelerator (cyclotron), beam transport system, energy selection system, and rotating gantry irradiation equipment. Due to its effectiveness in treating certain types of cancer, there has been a growing demand for proton therapy worldwide.
The List of Companies - Proton Therapy Systems Market
- Varian Medical Systems Inc
- Hitachi Ltd
- Sumitomo Heavy Industries Limited
- Ion Beam Applications SA
- Mevion Medical Systems
- Provision Healthcare LLC
- ProTom International
- Optivus Proton Therapy Inc
- Advanced Oncotherapy plc
- B dot Medical Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Mar 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Mar 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)